{"web_url": "http://dealbook.nytimes.com/2014/09/25/sam-waksals-new-biotech-venture-tests-investor-forgiveness/", "multimedia": [{"height": 126, "type": "image", "subtype": "wide", "legacy": {"wideheight": "126", "wide": "images/2014/09/26/business/dbpix-waksal/dbpix-waksal-thumbWide.jpg", "widewidth": "190"}, "width": 190, "url": "images/2014/09/26/business/dbpix-waksal/dbpix-waksal-thumbWide.jpg"}, {"height": 400, "type": "image", "subtype": "xlarge", "legacy": {"xlargeheight": "400", "xlarge": "images/2014/09/26/business/dbpix-waksal/dbpix-waksal-articleLarge.jpg", "xlargewidth": "600"}, "width": 600, "url": "images/2014/09/26/business/dbpix-waksal/dbpix-waksal-articleLarge.jpg"}, {"height": 75, "type": "image", "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/09/26/business/dbpix-waksal/dbpix-waksal-thumbStandard-v2.jpg", "thumbnailwidth": "75"}, "width": 75, "url": "images/2014/09/26/business/dbpix-waksal/dbpix-waksal-thumbStandard-v2.jpg"}], "subsection_name": "Dealbook", "print_page": null, "blog": [], "source": "The New York Times", "section_name": "Business Day", "abstract": "The former ImClone boss who went to prison for an insider trading scandal follows others given second-chances like Donald Trump, Robert Cyran of Reuters Breakingviews writes.", "type_of_material": "Blog", "lead_paragraph": null, "keywords": [{"value": "Meriwether, John W", "name": "persons", "rank": "1"}, {"value": "Trump, Donald J", "name": "persons", "rank": "2"}, {"value": "Waksal, Samuel", "name": "persons", "rank": "3"}, {"value": "ImClone Systems Inc", "name": "organizations", "rank": "1"}, {"value": "Long-Term Capital Management Lp", "name": "organizations", "rank": "2"}, {"value": "Biotechnology", "name": "subject", "rank": "1"}, {"value": "Initial Public Offerings", "name": "subject", "rank": "2"}], "pub_date": "2014-09-25T12:30:22Z", "byline": {"original": "By ROBERT CYRAN", "person": [{"role": "reported", "firstname": "Robert", "organization": "", "rank": 1, "lastname": "CYRAN"}]}, "_id": "5424459b38f0d8525e453151", "slideshow_credits": null, "word_count": "400", "news_desk": "Business", "headline": {"main": "Sam Waksal's New Biotech Venture Tests Investor Forgiveness", "kicker": "DealBook"}, "snippet": "The former ImClone boss who went to prison for an insider trading scandal follows others given second-chances like Donald Trump, Robert Cyran of Reuters Breakingviews writes....", "document_type": "blogpost"}